DI-014 Efficacy and safety of fingolimod in patients with relapsing remitting multiple sclerosis

BackgroundFingolimod represents a new class of treatment for patients with relapsing remitting multiple sclerosis (RRMS) because it allows oral administration and it also has a mechanism of action that targets not only the immune system but also neural cells.PurposeTo evaluate the efficacy and adver...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2016-03, Vol.23 (Suppl 1), p.A124-A124
Hauptverfasser:	Fernández-Ginés, FD, Nieto-Guindo, P, Rodríguez-Cuadros, TB, Alférez-García, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Multiple sclerosis Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!